A guide to systematic review and meta-analysis of prognostic factor studies
暂无分享,去创建一个
Richard D Riley | Kym I E Snell | Gary S Collins | Karel G M Moons | Joie Ensor | Lotty Hooft | Jill Hayden | Douglas G Altman | Thomas P A Debray | G. Collins | L. Hooft | D. Altman | R. Riley | J. Ensor | K. Moons | J. Hayden | K. Snell | T. Debray
[1] Richard D Riley,et al. Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes , 2013, BMJ : British Medical Journal.
[2] E. Steyerberg,et al. Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research , 2013, PLoS medicine.
[3] A. Sutton,et al. Comparison of two methods to detect publication bias in meta-analysis. , 2006, JAMA.
[4] L. Hedges,et al. Introduction to Meta‐Analysis , 2009, International Coaching Psychology Review.
[5] B. J. Ingui,et al. Searching for clinical prediction rules in MEDLINE. , 2001, Journal of the American Medical Informatics Association : JAMIA.
[6] David R. Jones,et al. A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma. , 2003, Health technology assessment.
[7] Richard D Riley,et al. Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.
[8] J. Ioannidis,et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.
[9] John P A Ioannidis,et al. Selective reporting biases in cancer prognostic factor studies. , 2005, Journal of the National Cancer Institute.
[10] R. Haynes,et al. Medline : analytical survey scientifically strong studies of diagnosis from Optimal search strategies for retrieving , 2004 .
[11] S Greenland,et al. Meta‐analysis of Epidemiologic Dose‐Response Data , 1993, Epidemiology.
[12] Patrick Royston,et al. A new measure of prognostic separation in survival data , 2004, Statistics in medicine.
[13] G. Collins,et al. External validation of multivariable prediction models: a systematic review of methodological conduct and reporting , 2014, BMC Medical Research Methodology.
[14] E. Steyerberg,et al. Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research , 2013, PLoS medicine.
[15] Douglas G Altman,et al. Systematic reviews of evaluations of prognostic variables , 2001, BMJ : British Medical Journal.
[16] Patrick Bossuyt,et al. Systematic Reviews of Diagnostic Test Accuracy , 2008, Annals of Internal Medicine.
[17] Larry V. Hedges,et al. Converting Among Effect Sizes , 2009, Introduction to Meta‐Analysis.
[18] D G Altman,et al. Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond , 2009, British Journal of Cancer.
[19] Richard D Riley,et al. Individual participant data meta-analysis of prognostic factor studies: state of the art? , 2012, BMC Medical Research Methodology.
[20] Richard D Riley,et al. Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples , 2017, British Medical Journal.
[21] R. Brian Haynes,et al. Developing Optimal Search Strategies for Detecting Sound Clinical Prediction Studies in MEDLINE , 2003, AMIA.
[22] Gary S Collins,et al. A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods. , 2013, Journal of clinical epidemiology.
[23] T. Perneger. Estimating the relative hazard by the ratio of logarithms of event-free proportions. , 2008, Contemporary clinical trials.
[24] Jian Qing Shi,et al. Meta‐analysis for trend estimation , 2004, Statistics in medicine.
[25] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[26] G. Collins,et al. Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist , 2014, PLoS medicine.
[27] C. Bombardier,et al. Assessing Bias in Studies of Prognostic Factors , 2013, Annals of Internal Medicine.
[28] Douglas G. Altman,et al. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration , 2012, PLoS medicine.
[29] Kunihiko Takahashi,et al. Meta‐analysis of prognostic studies for a biomarker with a study‐specific cutoff value , 2016, Research synthesis methods.
[30] A. Harris,et al. REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.
[31] D. Firth. Bias reduction of maximum likelihood estimates , 1993 .
[32] Richard D. Riley,et al. Random effects meta‐analysis: Coverage performance of 95% confidence and prediction intervals following REML estimation , 2016, Statistics in medicine.
[33] M. Leeflang,et al. Search Filters for Finding Prognostic and Diagnostic Prediction Studies in Medline to Enhance Systematic Reviews , 2012, PloS one.
[34] H Tunstall-Pedoe,et al. Systematically missing confounders in individual participant data meta-analysis of observational cohort studies , 2009, Statistics in medicine.
[35] D G Altman,et al. REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British journal of cancer.
[36] A. Harris,et al. Systematic Review of Multiple Studies of Prognosis: The Feasibility of Obtaining Individual Patient Data , 2007 .
[37] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[38] M. Hernán,et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.
[39] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[40] M. Sydes,et al. Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.
[41] J. Sterne,et al. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. , 2003, Health technology assessment.
[42] Douglas G. Altman,et al. Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols , 2014, PLoS medicine.
[43] G. Collins,et al. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting , 2011, BMC medicine.
[44] Yemisi Takwoingi,et al. Empirical Evidence of the Importance of Comparative Studies of Diagnostic Test Accuracy , 2013, Annals of Internal Medicine.
[45] Mark Woodward,et al. Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies , 2013, American journal of epidemiology.
[46] Richard D Riley,et al. Prognosis research strategy (PROGRESS) 4: Stratified medicine research , 2013, BMJ : British Medical Journal.
[47] S. Greenland,et al. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. , 1992, American journal of epidemiology.
[48] K. A. McKibbon,et al. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey , 2005, BMJ : British Medical Journal.
[49] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[50] Patrick Royston,et al. Reporting methods in studies developing prognostic models in cancer: a review , 2010, BMC medicine.
[51] P C Lambert,et al. Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future , 2003, British Journal of Cancer.
[52] Gerta Rücker,et al. Undue reliance on I2 in assessing heterogeneity may mislead , 2008, BMC medical research methodology.
[53] David J Spiegelhalter,et al. A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.
[54] Richard D Riley,et al. A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes , 2018, Statistical methods in medical research.
[55] C S Berkey,et al. A random-effects regression model for meta-analysis. , 1995, Statistics in medicine.
[56] L. Hooft,et al. A guide to systematic review and meta-analysis of prediction model performance , 2017, British Medical Journal.
[57] Patrick Royston,et al. Explained Variation for Survival Models , 2006 .
[58] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[59] Nicola Orsini,et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. , 2012, American journal of epidemiology.
[60] E. Steyerberg,et al. Reporting and Methods in Clinical Prediction Research: A Systematic Review , 2012, PLoS medicine.
[61] Richard D Riley,et al. Evidence-Based Assessment and Application of Prognostic Markers: The Long Way from Single Studies to Meta-Analysis , 2006 .
[62] R. Riley,et al. Detecting small‐study effects and funnel plot asymmetry in meta‐analysis of survival data: A comparison of new and existing tests , 2017, Research synthesis methods.
[63] M. Parmar,et al. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.
[64] Gary S Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.
[65] D G Altman,et al. Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines , 2004, British Journal of Cancer.
[66] Bette Jean Ingui,et al. Research Paper: Searching for Clinical Prediction Rules in MEDLINE , 2001, J. Am. Medical Informatics Assoc..
[67] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[68] Keith R. Abrams,et al. Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease , 2010, PLoS medicine.
[69] Karla Hemming,et al. Multivariate meta‐analysis of prognostic factor studies with multiple cut‐points and/or methods of measurement , 2015, Statistics in medicine.
[70] Richard D Riley,et al. Primer: an evidence-based approach to prognostic markers , 2005, Nature Clinical Practice Oncology.
[71] G. Guyatt,et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients , 2015, BMJ : British Medical Journal.
[72] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[73] J. Auget,et al. Advances in statistical methods for the health sciences : applications to cancer and AIDS studies, genome sequence analysis, and survival analysis , 2007 .
[74] Patrick Royston,et al. Reporting performance of prognostic models in cancer: a review , 2010, BMC medicine.
[75] R D Riley,et al. Random‐effects meta‐analysis of the clinical utility of tests and prediction models , 2018, Statistics in medicine.
[76] John P A Ioannidis,et al. Almost all articles on cancer prognostic markers report statistically significant results. , 2007, European journal of cancer.
[77] Douglas G Altman,et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). , 2005, European journal of cancer.
[78] Douglas G Altman,et al. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration , 2012, BMC Medicine.
[79] R. Riley,et al. Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.
[80] Hendriek C Boshuizen,et al. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. , 2006, American journal of epidemiology.
[81] J. Ioannidis,et al. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. , 2007, Journal of the National Cancer Institute.
[82] L. Hooft,et al. Implementing systematic reviews of prognosis studies in Cochrane. , 2018, The Cochrane database of systematic reviews.
[83] Cynthia D Mulrow,et al. Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change , 2014, Annals of Internal Medicine.
[84] J. Hartung,et al. A refined method for the meta‐analysis of controlled clinical trials with binary outcome , 2001, Statistics in medicine.
[85] Ewout W Steyerberg,et al. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests , 2016, British Medical Journal.
[86] Julian P T Higgins,et al. An empirical comparison of heterogeneity variance estimators in 12 894 meta‐analyses , 2015, Research synthesis methods.
[87] T Pérez,et al. Extraction of unadjusted estimates of prognostic association for meta-analysis: simulation methods as good alternatives to trend and direct method estimation. , 2017, Journal of clinical epidemiology.